G1 Therapeutics Inc (STU:G1H)
€ 6.39 0 (0%) Market Cap: 339.15 Mil Enterprise Value: 327.68 Mil PE Ratio: 0 PB Ratio: 15.31 GF Score: 32/100

Q2 2020 G1 Therapeutics Inc Earnings Call Transcript

Aug 05, 2020 / 09:00PM GMT
Release Date Price: €12.99 (+0.39%)
Operator

Ladies and gentlemen, thank you for standing by and welcome to the G1 Therapeutics Second Quarter 2020 Fiscal Results Conference Call. (Operator Instructions) I would now like to hand the conference over to your speaker today, Mr. Jeff Macdonald. Thank you. Please go ahead, sir.

Jeff Macdonald
G1 Therapeutics, Inc. - Senior Director of IR & Corporate Communications

Thank you, operator. Good afternoon, everyone, and welcome to the G1 Therapeutics Second Quarter 2020 Corporate Financial Update.

On today's call, Mark Velleca, Chief Executive Officer; Soma Gupta, Chief Commercial Officer; Raj Malik, Chief Medical Officer and Senior Vice President, R&D; and Jen Moses, Chief Financial Officer, will provide an update of the quarter with Q&A to follow.

Before we begin, I would like to remind you, this call will include forward-looking statements based on current expectations. Such statements represent management's judgment as of today and may involve risks and uncertainties that could cause actual results to differ materially from

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot